Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
Michallet M, Philip T, Philip I, Godinot H, Sebban C, Salles G, Thiebaut A, Biron P, Lopez F, Mazars P, Roubi N, Leemhuis T, Hanania E, Reading C, Fine G, Atkinson K, Juttner C, Coiffier B, Fière D, Archimbaud E.
Michallet M, et al. Among authors: roubi n.
Exp Hematol. 2000 Jul;28(7):858-70. doi: 10.1016/s0301-472x(00)00169-7.
Exp Hematol. 2000.
PMID: 10907648
Free article.
Clinical Trial.